BIOGEN PHARMACHEM INDUSTRIES L (BIOGEN.BO)
INR 1.21
(-1.63%)
INR 1.21
(-1.63%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 19.44 Million | 17.04 Million | 13.98 Million | 39.49 Million | -12.12 Million | 875.13 Thousand |
| Net Income | 19.3 Million | 4.55 Million | -85.93 Thousand | -16.03 Million | -1.16 Million | -35.47 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 139 Thousand | 12.48 Million | 14.06 Million | 55.53 Million | -10.95 Million | 910.61 Thousand |
| Other non-cash items | - | - | -24.79 Million | -55.46 Million | 10.87 Million | -910.61 Thousand |
| Investing Cash Flow | -20.56 Million | -16.58 Million | -13.22 Million | -36.39 Million | 15.36 Million | -7.24 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -18.99 Million | - | -30.43 Million | -2.02 Million | -11.3 Million |
| Sales/Maturities of investments | 34.1 Million | - | 25.39 Million | - | - | - |
| Other Investing Activities | -54.66 Million | 2.41 Million | -38.61 Million | -5.95 Million | 17.38 Million | 4.06 Million |
| Financing Cash Flow | - | - | - | -3.05 Million | -3.24 Million | 6.18 Million |
| Debt repayment | - | - | - | -3.05 Million | -3.24 Million | -6.18 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | 12.36 Million |
| Accounts receivables | - | - | 25.4 Million | 54.85 Million | 35.46 Thousand | -10 Million |
| Accounts payables | - | - | -608.47 Thousand | 608.47 Thousand | -10.91 Million | 10.91 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 139 Thousand | 12.48 Million | -10.72 Million | 68.75 Thousand | -79.98 Thousand | - |
| Cash at beginning of period | 1.28 Million | 831.69 Thousand | 74.38 Thousand | 33.48 Thousand | 30.96 Thousand | 217.44 Thousand |
| Cash at end of period | 169 Thousand | 1.28 Million | 831.69 Thousand | 74.38 Thousand | 33.48 Thousand | 30.96 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.11 Million | 455.3 Thousand | 757.31 Thousand | 40.9 Thousand | 2519.00 | -186.47 Thousand |
| Free Cash Flow | 19.44 Million | 17.04 Million | 13.98 Million | 39.49 Million | -12.12 Million | 875.13 Thousand |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 19.3 Million | 623 Thousand | 7.2 Million | 4.06 Million | 4.55 Million | -1.96 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 139 Thousand | - | - | - | 12.48 Million | - |
| Other non-cash items | - | -623 Thousand | -7.2 Million | -4.06 Million | - | 1.96 Million |
| Investing Cash Flow | -20.56 Million | - | - | - | -16.58 Million | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | -18.99 Million | - |
| Sales/Maturities of investments | 34.1 Million | - | - | - | - | - |
| Other Investing Activities | -54.66 Million | - | - | - | 2.41 Million | - |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 139 Thousand | - | - | - | 12.48 Million | - |
| Cash at beginning of period | 1.28 Million | 186 Thousand | -7.01 Million | 1.28 Million | 831.69 Thousand | 3.25 Million |
| Cash at end of period | 169 Thousand | 623 Thousand | 186 Thousand | 4.06 Million | 1.28 Million | 1.28 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.11 Million | 437 Thousand | 7.2 Million | 2.78 Million | 455.3 Thousand | -1.96 Million |
| Free Cash Flow | 19.44 Million | 623 Thousand | 7.2 Million | 4.06 Million | 17.04 Million | -1.96 Million |
PARKERAC
688611
SHK
STEP2COR
002989
4848